CHEBI:71193 - liraglutide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name liraglutide
ChEBI ID CHEBI:71193
Definition A lipopeptide that is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. Used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C172H265N43O51
Net Charge 0
Average Mass 3751.20200
Monoisotopic Mass 3748.946
InChI InChI=1S/C172H265N43O51/c1-18-20-21-22-23-24-25-26-27-28-29-30-37-53-129(224)195-116(170(265)266)59-64-128(223)180-68-41-40-50-111(153(248)199-115(62-67-135(232)233)154(249)204-120(73-100-44-33-31-34-45-100)159(254)214-140(93(11)19-2)167(262)192-97(15)146(241)201-122(76-103-79-183-108-49-39-38-48-106(103)108)157(252)203-118(72-90(5)6)158(253)212-138(91(7)8)165(260)200-110(52-43-70-182-172(177)178)149(244)184-81-130(225)193-109(51-42-69-181-171(175)176)148(243)187-84-137(236)237)196-144(239)95(13)189-143(238)94(12)191-152(247)114(58-63-127(174)222)194-131(226)82-185-151(246)113(61-66-134(230)231)198-155(250)117(71-89(3)4)202-156(251)119(75-102-54-56-105(221)57-55-102)205-162(257)124(85-216)208-164(259)126(87-218)209-166(261)139(92(9)10)213-161(256)123(78-136(234)235)206-163(258)125(86-217)210-169(264)142(99(17)220)215-160(255)121(74-101-46-35-32-36-47-101)207-168(263)141(98(16)219)211-132(227)83-186-150(245)112(60-65-133(228)229)197-145(240)96(14)190-147(242)107(173)77-104-80-179-88-188-104/h31-36,38-39,44-49,54-57,79-80,88-99,107,109-126,138-142,183,216-221H,18-30,37,40-43,50-53,58-78,81-87,173H2,1-17H3,(H2,174,222)(H,179,188)(H,180,223)(H,184,244)(H,185,246)(H,186,245)(H,187,243)(H,189,238)(H,190,242)(H,191,247)(H,192,262)(H,193,225)(H,194,226)(H,195,224)(H,196,239)(H,197,240)(H,198,250)(H,199,248)(H,200,260)(H,201,241)(H,202,251)(H,203,252)(H,204,249)(H,205,257)(H,206,258)(H,207,263)(H,208,259)(H,209,261)(H,210,264)(H,211,227)(H,212,253)(H,213,256)(H,214,254)(H,215,255)(H,228,229)(H,230,231)(H,232,233)(H,234,235)(H,236,237)(H,265,266)(H4,175,176,181)(H4,177,178,182)/t93-,94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1
InChIKey YSDQQAXHVYUZIW-QCIJIYAXSA-N
SMILES CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O
Roles Classification
Biological Role(s): glucagon-like peptide-1 receptor agonist
An agonist that binds to and activates glucagon-like peptide-1 (GLP-1) receptors.
Application(s): neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing liraglutide (CHEBI:71193) has role glucagon-like peptide-1 receptor agonist (CHEBI:71196)
liraglutide (CHEBI:71193) has role neuroprotective agent (CHEBI:63726)
liraglutide (CHEBI:71193) is a lipopeptide (CHEBI:46895)
liraglutide (CHEBI:71193) is a polypeptide (CHEBI:15841)
IUPAC Name
N2-(L-histidyl-L-alanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl)-N6-(N-hexadecanoyl-L-γ-glutamyl)-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginylglycine
INNs Sources
liraglutida ChemIDplus
liraglutide KEGG DRUG
liraglutide WHO MedNet
liraglutidum ChemIDplus
Synonyms Sources
NN 2211 ChemIDplus
NN-2211 ChemIDplus
NN2211 ChemIDplus
Brand Name Source
Victoza KEGG DRUG
Database Links Databases
4164 DrugCentral
D06404 KEGG DRUG
DB06655 DrugBank
Liraglutide Wikipedia
US2006160736 Patent
WO2008011518 Patent
View more database links
Registry Numbers Types Sources
10331362 Reaxys Registry Number Reaxys
204656-20-2 CAS Registry Number ChemIDplus
204656-20-2 CAS Registry Number KEGG DRUG
Citations Waiting for Citations Types Sources
21964769 PubMed citation Europe PMC
22038829 PubMed citation Europe PMC
22051096 PubMed citation Europe PMC
22245694 PubMed citation Europe PMC
22338093 PubMed citation Europe PMC
22382611 PubMed citation Europe PMC
22405264 PubMed citation Europe PMC
22443187 PubMed citation Europe PMC
22446097 PubMed citation Europe PMC
22536087 PubMed citation Europe PMC
22569791 PubMed citation Europe PMC
22587909 PubMed citation Europe PMC
22592020 PubMed citation Europe PMC
22727533 PubMed citation Europe PMC
22846777 PubMed citation Europe PMC
22851600 PubMed citation Europe PMC
22862847 PubMed citation Europe PMC
22927782 PubMed citation Europe PMC
22938097 PubMed citation Europe PMC
22958381 PubMed citation Europe PMC
22973968 PubMed citation Europe PMC
22985213 PubMed citation Europe PMC
23068961 PubMed citation Europe PMC
23082308 PubMed citation Europe PMC
23149376 PubMed citation Europe PMC
Last Modified
22 February 2017